The invention provides a liposome for delivery to the posterior segment of the eye, comprising (A) a phospholipid, (B) a charged substance, and/or (C) a membrane-reinforcing substance; the liposome having a rigidity that provides the liposome with cell membrane permeability, and having a mean particle diameter of 1 µm or less; and a pharmaceutical composition for a disease in the posterior segment of an eye, comprising a drug encapsulated in the liposome. The liposome is delivered to the posterior segment of the eye by instillation, and is non-cytotoxic; and the pharmaceutical composition for a disease in the posterior segment of the eye comprises the liposome.
本发明提供了一种用于向眼球后段给药的脂质体,包括(A)
磷脂、(B)带电物质和/或(C)膜强化物质;脂质体具有一定的硬度,使脂质体具有细胞膜渗透性,且平均颗粒直径为1微米或更小;以及一种治疗眼球后段疾病的药物组合物,包括封装在脂质体中的药物。脂质体通过灌注输送到眼球后段,无细胞毒性;治疗眼球后段疾病的药物组合物包括脂质体。